Literature DB >> 20739182

The clinical importance of understanding the evolution of papillomaviruses.

Ignacio G Bravo1, Silvia de Sanjosé, Marc Gottschling.   

Abstract

A significant fraction of human cancers is associated with infections by different papillomaviruses (PVs). In other vertebrates, the presence of specific PVs is also associated with different neoplasias. The popular view of PVs conceives them to be largely static and relies on generalized assumptions that have rarely been rigorously tested such as: virus-host codivergence, strict tissue tropism and host-specificity, their very low mutation rate and the absence of recombination. Here, we want to stress the need and the medical importance of understanding the evolutionary history and present-day dynamics of PVs. Understanding the way that PV genomes have evolved will clarify the link between a given genotype and the phenotypic and clinical outcome of the corresponding viral infection.
Copyright © 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Year:  2010        PMID: 20739182     DOI: 10.1016/j.tim.2010.07.008

Source DB:  PubMed          Journal:  Trends Microbiol        ISSN: 0966-842X            Impact factor:   17.079


  27 in total

1.  Genome characterization of a bovine papillomavirus type 5 from cattle in the Amazon region, Brazil.

Authors:  Flavio R C da Silva; Cíntia Daudt; Samuel P Cibulski; Matheus N Weber; Ana Paula M Varela; Fabiana Q Mayer; Paulo M Roehe; Cláudio W Canal
Journal:  Virus Genes       Date:  2016-11-05       Impact factor: 2.332

2.  Papillomaviruses: evolution, Linnaean taxonomy and current nomenclature.

Authors:  Koenraad Van Doorslaer; Hans-Ulrich Bernard; Zigui Chen; Ethel-Michelle de Villiers; Harald zur Hausen; Robert D Burk
Journal:  Trends Microbiol       Date:  2010-12-07       Impact factor: 17.079

3.  Identification and evolutionary analysis of papillomavirus sequences in New World monkeys (genera Sapajus and Alouatta) from Argentina.

Authors:  C Sanchez-Fernandez; E M Bolatti; A C A Culasso; D Chouhy; M M Kowalewski; E J Stella; T G Schurr; M A Rinas; D J Liotta; R H Campos; A A Giri; I Badano
Journal:  Arch Virol       Date:  2022-03-30       Impact factor: 2.574

Review 4.  Human papillomavirus infections: warts or cancer?

Authors:  Louise T Chow; Thomas R Broker
Journal:  Cold Spring Harb Perspect Biol       Date:  2013-07-01       Impact factor: 10.005

5.  Identification of a Novel Papillomavirus Type (MfoiPV1) Associated with Acrochordon in a Stone Marten (Martes foina).

Authors:  Urška Kuhar; Diana Žele Vengušt; Urška Jamnikar-Ciglenečki; Gorazd Vengušt
Journal:  Pathogens       Date:  2021-04-30

6.  Next-generation sequencing of cervical DNA detects human papillomavirus types not detected by commercial kits.

Authors:  Tracy L Meiring; Anna T Salimo; Beatrix Coetzee; Hans J Maree; Jennifer Moodley; Inga I Hitzeroth; Michael-John Freeborough; Ed P Rybicki; Anna-Lise Williamson
Journal:  Virol J       Date:  2012-08-16       Impact factor: 4.099

7.  The combined influence of oral contraceptives and human papillomavirus virus on cutaneous squamous cell carcinoma.

Authors:  Jimmy T Efird; Amanda E Toland; C Suzanne Lea; Christopher J Phillips
Journal:  Clin Med Insights Oncol       Date:  2011-03-27

Review 8.  Papillomaviruses: Viral evolution, cancer and evolutionary medicine.

Authors:  Ignacio G Bravo; Marta Félez-Sánchez
Journal:  Evol Med Public Health       Date:  2015-01-28

9.  In Silico Design and Immunological Studies of Two Novel Multiepitope DNA-Based Vaccine Candidates Against High-Risk Human Papillomaviruses.

Authors:  Matin Kayyal; Azam Bolhassani; Zahra Noormohammadi; Majid Sadeghizadeh
Journal:  Mol Biotechnol       Date:  2021-07-25       Impact factor: 2.695

10.  E4 antibodies facilitate detection and type-assignment of active HPV infection in cervical disease.

Authors:  Heather Griffin; Zhonglin Wu; Rebecca Marnane; Vincent Dewar; Anco Molijn; Wim Quint; Christine Van Hoof; Frank Struyf; Brigitte Colau; David Jenkins; John Doorbar
Journal:  PLoS One       Date:  2012-12-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.